UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000017004
Receipt No. R000019647
Scientific Title Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma.
Date of disclosure of the study information 2016/02/01
Last modified on 2016/02/10 16:00:14

No. Disposal Last modified on Item of update
1 Insert 2015/04/01 10:39:46
2 Update 2015/04/01 10:41:53 Date of disclosure of the study information
3 Update 2015/04/25 18:07:41 Date of disclosure of the study information
4 Update 2015/06/15 08:29:46 Date of disclosure of the study information
5 Update 2015/06/15 08:30:54 Date of protocol fixation
Anticipated trial start date
6 Update 2015/06/15 08:33:17 Date of disclosure of the study information
7 Update 2015/07/25 17:15:07 Date of disclosure of the study information
8 Update 2015/07/25 17:18:13 Date of protocol fixation
Anticipated trial start date
9 Update 2016/01/30 21:51:30 Recruitment status
10 Update 2016/02/10 16:00:14 Interventions/Control_1
Interventions/Control_1


Contact us.